Transcode Therapeutics, Inc.
RNAZ- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829635
No open-market purchases or sales by Transcode Therapeutics, Inc. insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $208.1K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Transcode Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- −5 vs. Q2 2024
- Shares held
- 325.3K
- +63.2K (+24.1%) vs. Q2 2024
- Total value
- $185.8K
- −$77.2K (−29.4%) vs. Q2 2024
- New holders
- 3
- 5 more added
- Sold out
- 8
- 1 more reduced
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RNAZ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $208.1K |
| Q1 2026 | 8 | $265.7K |
| Q4 2025 | 6 | $26.4K |
| Q3 2025 | 8 | $155.0K |
| Q2 2025 | 9 | $237.0K |
| Q1 2025 | 19 | $1.06M |
| Q4 2024 | 5 | $33.4K |
| Q3 2024 | 10 | $185.8K |
| Q2 2024 | 15 | $263.0K |
| Q1 2024 | 7 | $284.1K |
| Q4 2023 | 13 | $105.4K |
| Q3 2023 | 11 | $281.6K |
| Q2 2023 | 5 | $476.6K |
| Q1 2023 | 11 | $88.6K |
| Q4 2022 | 18 | $222.5K |
| Q3 2022 | 13 | $2.27M |
| Q2 2022 | 13 | $2.67M |
| Q1 2022 | 13 | $3.14M |
| Q4 2021 | 16 | $5.98M |
| Q3 2021 | 17 | $7.28M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Transcode Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 121,768 | $69.5K | 0.00% | +83,370+217.1% | Added |
| Private Capital Management LLC | 80,675 | $46.1K | 0.01% | +63,157+360.5% | Added |
| Sheets Smith Wealth Management | 50,138 | $28.6K | 0.00% | +30,000+149.0% | Added |
| Jane Street Group, LLC | 39,706 | $22.7K | 0.00% | +39,706 | New |
| Captrust Financial Advisors | 16,250 | $9.28K | 0.00% | +5,000+44.4% | Added |
| Morgan Stanley | 10,000 | $5.71K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,474 | $3.70K | 0.00% | −1,399−17.8% | Reduced |
| FMR LLC | 175 | $100 | 0.00% | +175 | New |
| Bank of America Corp | 141 | $81 | 0.00% | +86+156.4% | Added |
| Danske Bank A/S | 2 | $1 | 0.00% | +2 | New |
| UBS Group AG | 0 | $0 | 0.00% | −74,924−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −25,512−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −24,253−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,358−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −12,854−100.0% | Sold out |
| Financial Network Wealth Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| First Personal Financial Services | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −1−100.0% | Sold out |